Version in force 1 October 2021

Previous version, in force 10 May 2021 02008R1272-20210510 → this version, in force 1 October 2021 02008R1272-20211001

ANNEX II SPECIAL RULES FOR LABELLING AND PACKAGING OF CERTAIN SUBSTANCES AND MIXTURES This Annex consists of 5 parts: Part 1 contains special rules for the labelling of certain classified substances and mixtures. Part 2 sets out rules for additional hazard statements to be … 620 unchanged words … mixtures in addition to classification for skin corrosivity, if no acute inhalation test data are available and which may be inhaled. 2. PART 2: SPECIAL RULES FOR SUPPLEMENTAL LABEL ELEMENTS FOR CERTAIN MIXTURES The statements set out in sections 2.1 to 2.10 and 2.12 shall be assigned to mixtures in accordance with Article 25(6). 2.1. Mixtures containing lead The label on the packaging of paints and varnishes containing lead in quantities exceeding 0,15 % (expressed as weight of metal) of the total weight of the mixture, … 731 unchanged words … exposure limits the label on the packaging shall bear the statement: EUH210 — Safety data sheet available on request. 2.11 Aerosols Note that aerosols are also subject to the labelling provisions in accordance with points 2.2 and 2.3 in the Annex to Directive 75/324/EEC. 2.12. Mixtures containing titanium dioxide The label on the packaging of liquid mixtures containing 1 % or more of titanium dioxide particles with aerodynamic diameter equal to or below 10 μm shall bear the following statement: EUH211: Warning! Hazardous respirable droplets may be formed when sprayed. Do not breathe spray or mist. The label on the packaging of solid mixtures containing 1 % or more of titanium dioxide shall bear the following statement: EUH212: Warning! Hazardous respirable dust may be formed when used. Do not breathe dust. In addition, the label on the packaging of liquid and solid mixtures not intended for the general public and not classified as hazardous which are labelled with EUH211 or EUH212, shall bear statement EUH210. 3. PART 3: SPECIAL RULES ON PACKAGING 3.1. Provisions relating to child-resistant fastenings 3.1.1. Packaging to be fitted with child-resistant fastenings 3.1.1.1. Packaging of whatever capacity containing a substance or mixture supplied to the general public and classified for acute toxicity, categories 1 … 848 unchanged words … the following wording: EUH401 — To avoid risks to human health and the environment, comply with the instructions for use 5. PART 5: LIST OF HAZARDOUS SUBSTANCES AND MIXTURES TO WHICH ARTICLE 29(3) APPLIES Ready mixed cement and concrete in the wet state.

Previous version, in force 10 May 2021 02008R1272-20210510 → this version, in force 1 October 2021 02008R1272-20211001

compared line by line: this provision is too large to compare word by word, so a marked line is a line that changed somewhere

ANNEX III LIST OF HAZARD STATEMENTS, SUPPLEMENTAL HAZARD INFORMATION AND SUPPLEMENTAL LABEL ELEMENTS 1. Part 1: hazard statements … 2,748 unchanged lines … SL Varnosti list na voljo na zahtevo. FI Käyttöturvallisuustiedote toimitetaan pyynnöstä. SV Säkerhetsdatablad finns att rekvirera. EUH 211 Language BG Внимание! При пулверизация могат да се образуват опасни респирабилни капки. Не вдишвайте пулверизираната струя или мъгла. ES ¡Atención! Al rociar pueden formarse gotas respirables peligrosas. No respirar el aerosol. CS Pozor! Při postřiku se mohou vytvářet nebezpečné respirabilní kapičky. Nevdechujte aerosoly nebo mlhu. DA Advarsel! Der kan danne sig farlige respirable dråber, når der sprayes. Undgå indånding af spray eller tåge. DE Achtung! Beim Sprühen können gefährliche lungengängige Tröpfchen entstehen. Aerosol oder Nebel nicht einatmen. ET Hoiatus! Pihustamisel võivad tekkida ohtlikud sissehingatavad piisad. Pihustatud ainet või udu mitte sisse hingata. EL Προσοχή! Κατά τον ψεκασμό μπορούν να σχηματιστούν επικίνδυνα εισπνεύσιμα σταγονίδια. Μην αναπνέετε το εκνέφωμα ή τα σταγονίδια. EN Warning! Hazardous respirable droplets may be formed when sprayed. Do not breathe spray or mist. FR Attention! Des gouttelettes respirables dangereuses peuvent se former lors de la pulvérisation. Ne pas respirer les aérosols ni les brouillards. GA Aire! D’fhéadfaí braoiníní guaiseacha inanálaithe a chruthú nuair a spraeáiltear an táirge seo. Ná hanálaigh sprae ná ceo. HR Upozorenje! Pri prskanju mogu nastati opasne respirabilne kapljice. Ne udisati aerosol ni maglicu. IT Attenzione! In caso di vaporizzazione possono formarsi goccioline respirabili pericolose. Non respirare i vapori o le nebbie. LV Uzmanību! Izsmidzinot var veidoties bīstami ieelpojami pilieni. Ne smidzinājumu, ne miglu neieelpot. LT Atsargiai! Purškiant gali susidaryti pavojingų įkvepiamų lašelių. Neįkvėpti rūko ar aerozolio. HU Figyelem! Permetezés közben veszélyes, belélegezhető cseppek képződhetnek. A permetet vagy a ködöt nem szabad belélegezni. MT Twissija! Jista’ jifforma qtar perikoluż li jinġibed man-nifs meta tisprejja minn dan. Tiġbidx l-isprej jew l-irxiex man-nifs. NL Let op! Bij verneveling kunnen gevaarlijke inhaleerbare druppels worden gevormd. Spuitnevel niet inademen. PL Uwaga! W przypadku rozpylania mogą się tworzyć niebezpieczne respirabilne kropelki. Nie wdychać rozpylonej cieczy lub mgły. PT Atenção! Podem formar-se gotículas inaláveis perigosas ao pulverizar. Não respirar a pulverização ou névoas. RO Avertizare! Se pot forma picături respirabile periculoase la pulverizare. Nu respirați prin pulverizare sau ceață. SK Pozor! Pri rozprašovaní sa môžu vytvárať nebezpečné respirabilné kvapôčky. Nevdychujte aerosóly ani hmlu. SL Pozor! Pri razprševanju lahko nastanejo nevarne vdihljive kapljice. Ne vdihavajte razpršila ali meglic. FI Varoitus! Vaarallisia keuhkorakkuloihin kulkeutuvia pisaroita saattaa muodostua suihkutuksen yhteydessä. Älä hengitä suihketta tai sumua. SV Varning! Farliga respirabla droppar kan bildas vid sprejning. Inandas inte sprej eller dimma. EUH 212 Language BG Внимание! При употреба може да се образува опасен респирабилен прах. Не вдишвайте праха. ES ¡Atención! Al utilizarse, puede formarse polvo respirable peligroso. No respirar el polvo. CS Pozor! Při použití se může vytvářet nebezpečný respirabilní prach. Nevdechujte prach. DA Advarsel! Der kan danne sig farligt respirabelt støv ved anvendelsen. Undgå indånding af støv. DE Achtung! Bei der Verwendung kann gefährlicher lungengängiger Staub entstehen. Staub nicht einatmen. ET Hoiatus! Kasutamisel võib tekkida ohtlik sissehingatav tolm. Tolmu mitte sisse hingata. EL Προσοχή! Κατά τη χρήση μπορεί να σχηματιστεί επικίνδυνη εισπνεύσιμη σκόνη. Μην αναπνέετε τη σκόνη. EN Warning! Hazardous respirable dust may be formed when used. Do not breathe dust. FR Attention! Une poussière respirable dangereuse peut se former lors de l’utilisation. Ne pas respirer cette poussière. GA Aire! D’fhéadfaí deannach guaiseach inanálaithe a chruthú nuair a úsáidtear an táirge seo. Ná hanálaigh deannach. HR Upozorenje! Pri prskanju može nastati opasna respirabilna prašina. Ne udisati prašinu. IT Attenzione! In caso di utilizzo possono formarsi polveri respirabili pericolose. Non respirare le polveri. LV Uzmanību! Izmantojot var veidoties bīstami ieelpojami putekļi. Putekļus neieelpot. LT Atsargiai! Naudojant gali susidaryti pavojingų įkvepiamų dulkių. Neįkvėpti dulkių. HU Figyelem! Használatkor veszélyes, belélegezhető por képződhet. A port nem szabad belélegezni. MT Twissija! Meta jintuża dan, jista’ jifforma trab perikoluż li jinġibed man-nifs. Tiġbidx it-trab man-nifs. NL Let op! Bij gebruik kunnen gevaarlijke inhaleerbare stofdeeltjes worden gevormd. Stof niet inademen. PL Uwaga! W przypadku stosowania może się tworzyć niebezpieczny pył respirabilny. Nie wdychać pyłu. PT Atenção! Podem formar-se poeiras inaláveis perigosas ao pulverizar. Não respirar as poeiras. RO Avertizare! Se poate forma pulbere respirabilă periculoasă în timpul utilizării. Nu inspirați pulberea. SK Pozor! Pri použití sa môže vytvárať nebezpečný respirabilný prach. Nevdychujte prach. SL Pozor! Pri uporabi lahko nastane nevaren vdihljiv prah. Prahu ne vdihavajte. FI Varoitus! Vaarallista keuhkorakkuloihin kulkeutuvaa pölyä saattaa muodostua käytön yhteydessä. Älä hengitä pölyä. SV Varning! Farligt respirabelt damm kan bildas vid användning. Inandas inte damm. EUH 401 Language BG За да се избегнат рискове за човешкото здраве и околната среда, спазвайте инструкциите за употреба. ES A fin de evitar riesgos para las personas y el medio ambiente, siga las instrucciones de uso. CS Dodržujte pokyny pro používání, abyste se vyvarovali rizik pro lidské zdraví a životní prostředí. … 18 unchanged lines … SL Da bi se izognili tveganjem za ljudi in okolje, ravnajte v skladu z navodili za uporabo. FI Noudata käyttöohjeita ihmisen terveydelle ja ympäristölle aiheutuvien vaarojen välttämiseksi. SV För att undvika risker för människors hälsa och för miljön, följ bruksanvisningen.

Previous version, in force 10 May 2021 02008R1272-20210510 → this version, in force 1 October 2021 02008R1272-20211001

compared line by line: this provision is too large to compare word by word, so a marked line is a line that changed somewhere

ANNEX VI Harmonised classification and labelling for certain hazardous substances Part 1 of this Annex provides an introduction to the list of harmonised classification and labelling, including information listed for each entry and related classifications and hazard statements in Table 3. … 198 unchanged lines … Press. Gas (Ref. Liq.) Press. Gas (Diss.) Aerosols shall not be classified as gases under pressure (See Annex I, Part 2, Section 2.3.2.1, Note 2). Note V: If the substance is to be placed on the market as fibres (with diameter < 3 μm, length > 5 μm and aspect ratio ≥ 3:1) or particles of the substance fulfilling the WHO fibre criteria or as particles with modified surface chemistry, their hazardous properties must be evaluated in accordance with Title II of this Regulation, to assess whether a higher category (Carc. 1B or 1A) and/or additional routes of exposure (oral or dermal) should be applied. Note W: It has been observed that the carcinogenic hazard of this substance arises when respirable dust is inhaled in quantities leading to significant impairment of particle clearance mechanisms in the lung. This note aims to describe the particular toxicity of the substance; it does not constitute a criterion for classification according to this Regulation. 1.1.3.2. Notes relating to the classification and labelling of mixtures Note 1: The concentration stated or, in the absence of such concentrations, the generic concentrations set out in this Regulation are the percentages by weight of the metallic element calculated with reference to the total weight of the mixture. Note 2: The concentration of isocyanate stated is the percentage by weight of the free monomer calculated with reference to the total weight of the mixture. Note 3: The concentration stated is the percentage by weight of chromate ions dissolved in water calculated with reference to the total weight of the mixture. Note 5: The concentration limits for gaseous mixtures are expressed as volume per volume percentage. Note 7: Alloys containing nickel are classified for skin sensitisation when the release rate of 0,5 μg Ni/cm2/week, as measured by the European Standard reference test method EN 1811, is exceeded. Note 8: The classification as a carcinogen shall apply unless it can be shown that the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is less than 0,1 %. Note 9: The classification as a mutagen shall apply unless it can be shown that the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is less than 1 %. Note 10: The classification as a carcinogen by inhalation applies only to mixtures in powder form containing 1 % or more of titanium dioxide which is in the form of or incorporated in particles with aerodynamic diameter ≤ 10 μm. 1.1.4. Information related to the classification and labelling of each entry in Table 3.2 1.1.4.1. Classification codes The classification for each category of danger (as defined in Article 2(2) of Directive 67/548/EEC) is normally presented in the form of an abbreviation representing the category of danger together with the appropriate risk phrase or phrases. However, in some cases (i.e. substances classified as flammable, sensitising and some substances classified as dangerous for the environment) the risk phrase alone is used; … 4,224 unchanged lines … H411 GHS05 GHS09 Dgr H318 H411 015-188-00-X (1-methylethylidene)di-4,1-phenylenetetraphenyl diphosphate 425-220-8 5945-33-5 Aquatic Chronic 4 H413 — H413 015-189-00-5 phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide 423-340-5 162881-26-7 Skin Sens. 1 H411 015-188-00-X (1-methylethylidene)di-4,1-phenylenetetraphenyl diphosphate 425-220-8 5945-33-5 Aquatic Chronic 4 H413 — H413 015-189-00-5 phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide 423-340-5 162881-26-7 Skin Sens. 1A Aquatic Chronic 4 H317 H413 GHS07 Wng H317 … 1,010 unchanged lines … Dgr H228 H314 H317 H413 023-001-00-8 divanadium pentaoxide; H413 022-006-00-2 titanium dioxide; [in powder form containing 1 % or more of particles with aerodynamic diameter ≤ 10 μm] 236-675-5 13463-67-7 Carc. 2 H351 (inhalation) GHS08 Wng H351 (inhalation) V, W, 10 023-001-00-8 divanadium pentaoxide; vanadium pentoxide 215-239-8 1314-62-1 Muta. 2 Repr. 2 STOT RE 1 … 483 unchanged lines … H317 GHS05 GHS07 Dgr H314 H317 027-001-00-9 cobalt 231-158-0 7440-48-4 Resp. Sens. 1 H317 027-001-00-9 cobalt 231-158-0 7440-48-4 Carc. 1B Muta. 2 Repr. 1B Resp. Sens. 1 Skin Sens. 1 Aquatic Chronic 4 H334 Aquatic Chronic 4 H350 H341 H360F H334 H317 H413 GHS08 Dgr H334 Dgr H350 H341 H360F H334 H317 H413 027-002-00-4 cobalt oxide 215-154-6 1307-96-6 Acute Tox. 4 * Skin Sens. 1 … 541 unchanged lines … H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥ 0,01 % M=1 028-018-00-4 nickel bis(sulfamidate); nickel sulfamate 237-396-1 13770-89-3 Carc. 1A Muta. 2 nickel sulfamate 237-396-1 13770-89-3 Carc. 1A Muta. 2 Repr. 1B Acute Tox. 4 STOT RE 1 Resp. Sens. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H350i H341 H360D*** H372** H360D*** H302 H372** H334 H317 H400 H410 GHS08 GHS07 GHS09 Dgr H350i H341 H360D*** H372** H360D*** H302 H372** H334 H317 H410 STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317:C ≥ 0,01 % M=1 028-019-00-X nickel bis(tetrafluoroborate) 238-753-4 14708-14-6 Carc. 1A Muta. 2 H410 oral: ATE = 853 mg/kg bw (anhydrate) oral: ATE = 1098 mg/kg bw (tetrahydrate) STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1 % ≤ C < 1 % Skin Sens. 1; H317: C ≥ 0,01 % M = 1 028-019-00-X nickel bis(tetrafluoroborate) 238-753-4 14708-14-6 Carc. 1A Muta. 2 Repr. 1B STOT RE 1 Resp. Sens. 1 … 2,568 unchanged lines … GHS09 Dgr H301 H372 ** H314 H410 081-001-00-3 thallium 231-138-1 7440-28-0 Acute Tox. 2 * H410 080-012-00-0 methylmercuric chloride 204-064-2 115-09-3 Carc. 2 Repr. 1A Lact. Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H360Df H362 H330 H310 H300 H372 (nervous system, kidneys) H400 H410 GHS08 GHS06 GHS09 Dgr H351 H360Df H362 H330 H310 H300 H372 (nervous system, kidneys) H410 inhalation: ATE = 0,05 mg/l (dusts or mists) dermal: ATE = 50 mg/kg bw oral: ATE = 5 mg/kg bw 1 081-001-00-3 thallium 231-138-1 7440-28-0 Acute Tox. 2 * Acute Tox. 2 * STOT RE 2 * Aquatic Chronic 4 H330 … 1,177 unchanged lines … H336 D 601-088-00-9 4-vinylcyclohexene 202-848-9 100-40-3 Carc. 2 H351 GHS08 Wng H351 601-089-00-4 muscalure; cis-tricos-9-ene 248-505-7 27519-02-4 Skin Sens. 1B H317 GHS07 Wng H317 602-001-00-7 chloromethane; Wng H317 601-090-00-X benzo[rst]pentaphene 205-877-5 189-55-9 Carc. 1B Muta. 2 H350 H341 GHS08 Dgr H350 H341 601-091-00-5 dibenzo[b,def]chrysene; dibenzo[a,h]pyrene 205-878-0 189-64-0 Carc. 1B Muta. 2 H350 H341 GHS08 Dgr H350 H341 602-001-00-7 chloromethane; methyl chloride 200-817-4 74-87-3 Flam. Gas 1 Press. Gas Carc. 2 … 1,540 unchanged lines … H302 H336 EUH019 EUH066 603-023-00-X ethylene oxide; oxirane 200-849-9 75-21-8 Press. Gas Flam. Gas 1 oxirane 200-849-9 75-21-8 Flam. Gas 1 Press. Gas Carc. 1B Muta. 1B Acute Tox. 3 * Eye Irrit. 2 Repr. 1B Acute Tox. 3 Acute Tox. 3 STOT SE 3 Skin Irrit. 2 H220 STOT SE 3 STOT RE 1 Skin Corr. 1 Eye Dam. 1 H220 H350 H340 H360Fd H331 H319 H301 H335 H315 GHS02 GHS04 H336 H372 (nervous system) H314 H318 GHS02 GHS08 GHS06 GHS08 GHS05 Dgr H220 H350 H340 H360Fd H331 H319 H301 H335 H315 U H336 H372 (nervous system) H314 inhalation: ATE = 700ppm (gases) oral: ATE = 100 mg/kg bw U 603-024-00-5 1,4-dioxane 204-661-8 123-91-1 Flam. Liq. 2 Carc. 2 Eye Irrit. 2 … 1,481 unchanged lines … 204-811-2 [3] 78-70-6 [1] 126-90-9 [2] 126-91-0 [3] Skin Sens. 1B H317 GHS07 Wng H317 604-001-00-2 phenol; carbolic acid; monohydroxybenzene; phenylalcohol 203-632-7 108-95-2 Muta. 2 Wng H317 603-236-00-8 ethanol, 2,2’-iminobis-, N-(C13-15-branched and linear alkyl) derivs. 308-208-6 97925-95-6 Repr. 1B H360D GHS08 Dgr H360D 604-001-00-2 phenol; carbolic acid; monohydroxybenzene; phenylalcohol 203-632-7 108-95-2 Muta. 2 Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Skin Corr. 1B H341 … 845 unchanged lines … H341 H335 H319 605-004-00-1 2,4,6-trimethyl-1,3,5-trioxane; paraldehyde 204-639-8 123-63-7 Flam. Liq. 3 H226 GHS02 Wng H226 605-005-00-7 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane; metaldehyde 203-600-2 108-62-3 Flam. Sol. 2 Acute Tox. 4 * H228 H302 GHS02 GHS07 Wng H228 H302 605-006-00-2 butyraldehyde 204-646-6 123-72-8 Flam. Liq. 2 H225 GHS02 Wng H226 605-005-00-7 metaldehyde (ISO); 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane 203-600-2 108-62-3 Flam. Sol. 2 Repr. 2 Acute Tox. 3 Aquatic Chronic 3 H228 H361f H301 H412 GHS02 GHS08 GHS06 Dgr H228 H361f H301 H412 oral: ATE = 283 mg/kg bw 605-006-00-2 butyraldehyde 204-646-6 123-72-8 Flam. Liq. 2 H225 GHS02 Dgr H225 605-007-00-8 1,1-dimethoxyethane; dimethyl acetal 208-589-8 534-15-6 Flam. Liq. 2 H225 GHS02 Dgr H225 605-008-00-3 acrolein; prop-2-enal; acrylaldehyde 203-453-4 107-02-8 Flam. Liq. 2 Acute Tox. 1 … 626 unchanged lines … Wng H410 606-046-00-3 reaction mass of cis-and trans-cyclohexadec-8-en-1-one 401-700-2 3100-36-5 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 606-047-00-9 2-benzyl-2-dimethylamino-4′-morpholinobutyrophenone 404-360-3 119313-12-1 Repr. 1B Wng H410 606-047-00-9 2-benzyl-2-dimethylamino-4'-morpholinobutyrophenone 404-360-3 119313-12-1 Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 H360D H400 … 2,381 unchanged lines … H335 H315 607-230-00-6 2-ethylhexanoic acid 205-743-6 149-57-5 Repr. 2 H361d *** GHS08 Wng H361d *** 607-231-00-1 clopyralid (ISO); 3,6-dichloropyridine-2-carboxylic acid 216-935-4 1702-17-6 Eye Dam. 1 H318 GHS05 Dgr H318 607-232-00-7 pyridate (ISO); O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate 259-686-7 55512-33-9 Skin Irrit. 2 Dgr H318 607-232-00-7 pyridate (ISO); O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate 259-686-7 55512-33-9 Acute Tox. 4 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H315 Aquatic Chronic 1 H302 H315 H317 H400 H410 GHS07 GHS09 Wng H315 Wng H302 H315 H317 H410 607-233-00-2 hexyl acrylate 219-698-5 2499-95-8 Eye Irrit. 2 H410 oral: ATE = 500 mg/kg bw M = 1 M = 10 607-233-00-2 hexyl acrylate 219-698-5 2499-95-8 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Skin Sens. 1 … 147 unchanged lines … H331 H312 H302 H400 607-247-00-9 dodecyl methacrylate 205-570-6 142-90-5 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 Aquatic Acute 1 Aquatic Chronic 1 H319 H335 H315 H400 H410 GHS07 GHS09 Wng H319 H335 H315 H410 STOT SE 3; H335: C ≥ 10 % 607-248-00-4 naptalam-sodium (ISO); sodium N-naphth-1-ylphthalamate 205-073-4 132-67-2 Acute Tox. 4 * H302 GHS07 H400 607-247-00-9 dodecyl methacrylate 205-570-6 142-90-5 STOT SE 3 H335 GHS07 Wng H335 STOT SE 3; H335: C ≥ 10 % 607-248-00-4 naptalam-sodium (ISO); sodium N-naphth-1-ylphthalamate 205-073-4 132-67-2 Acute Tox. 4 * H302 GHS07 Wng H302 607-249-00-X (1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate 256-032-2 42978-66-5 Eye Irrit. 2 STOT SE 3 Skin Irrit. 2 … 2,462 unchanged lines … GHS05 Dgr H361d H302 H318 608-001-00-3 acetonitrile; cyanomethane 200-835-2 75-05-8 Flam. Liq. 2 H318 607-733-00-0 cyflumetofen (ISO); 2-methoxyethyl (RS)-2-(4-tert-butylphenyl)-2-cyano-3-oxo-3-(α,α,α-trifluoro-o-tolyl)propionate — 400882-07-7 Carc. 2 Skin Sens. 1A H351 H317 GHS08 GHS07 Wng H351 H317 607-734-00-6 pentapotassium 2,2’,2’’,2’’’,2’’’’-(ethane-1,2-diylnitrilo)pentaacetate 404-290-3 7216-95-7 Acute Tox. 4 STOT RE 2 Eye Irrit. 2 H332 H373 (inhalation) H319 GHS08 GHS07 Wng H332 H373 (inhalation) H319 inhalation: ATE = 1,5 mg/l (dusts or mists) 607-735-00-1 N-carboxymethyliminobis(ethylenenitrilo)tetra(acetic acid) 200-652-8 67-43-6 Acute Tox. 4 STOT RE 2 Eye Irrit. 2 H332 H373 (inhalation) H319 GHS08 GHS07 Wng H332 H373 (inhalation) H319 inhalation: ATE = 1,5 mg/l (dusts or mists) 607-736-00-7 pentasodium (carboxylatomethyl)iminobis(ethylenenitrilo)tetraacetate 205-391-3 140-01-2 Acute Tox. 4 STOT RE 2 H332 H373 (inhalation) GHS08 GHS07 Wng H332 H373 (inhalation) inhalation: ATE = 1,5 mg/l (dusts or mists) 607-737-00-2 diisohexyl phthalate 276-090-2 71850-09-4 Repr. 1B H360FD GHS08 Dgr H360FD 608-001-00-3 acetonitrile; cyanomethane 200-835-2 75-05-8 Flam. Liq. 2 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * Eye Irrit. 2 H225 H332 … 301 unchanged lines … H411 GHS07 GHS09 Wng H302 H411 608-039-00-0 2-phenylhexanenitrile 423-460-8 3508-98-3 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 H411 608-039-00-0 2-phenylhexanenitrile 423-460-8 3508-98-3 Acute Tox. 4 Aquatic Chronic 2 H302 H411 GHS07 GHS09 Wng H302 H410 608-040-00-6 4,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile) 423-490-1 130755-46-3 Aquatic Acute 1 H411 oral: ATE = 500 mg/kg bw 608-040-00-6 4,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile) 423-490-1 130755-46-3 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 608-041-00-1 4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile 423-500-4 138401-24-8 Aquatic Acute 1 … 195 unchanged lines … 608-067-00-3 3,7-dimethylocta-2,6-dienenitrile 225-918-0 5146-66-7 Muta. 1B H340 GHS08 Dgr H340 608-068-00-9 flutianil (ISO); (2Z)-{[2-fluoro-5-(trifluoromethyl)phenyl]thio}[3-(2-methoxyphenyl)-1,3-thiazolidin-2-ylidene]acetonitrile — 958647-10-4 Aquatic Chronic 1 H410 GHS09 Wng H410 M = 100 609-001-00-6 1-nitropropane 203-544-9 108-03-2 Flam. Liq. 3 Wng H410 M = 100 608-069-00-4 fludioxonil (ISO); 4-(2,2-difluoro-1,3-benzodioxol-4-yl)-1H-pyrrole-3-carbonitrile — 131341-86-1 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 1 M = 10 609-001-00-6 1-nitropropane 203-544-9 108-03-2 Flam. Liq. 3 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * H226 … 6,131 unchanged lines … GHS09 Wng H319 H315 H410 613-054-00-0 thiabendazol (ISO);2-(thiazole-4-yl)benzimidazole 205-725-8 148-79-8 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 613-054-00-0 thiabendazole (ISO); 2-(thiazol-4-yl)benzimidazole 205-725-8 148-79-8 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 613-056-00-1 1,2-dimethyl-3,5-diphenylpyra zolium methylsulphate; difenzoquat methyl sulfate 256-152-5 43222-48-6 Acute Tox. 4 * Wng H410 M = 1 M = 1 613-056-00-1 1,2-dimethyl-3,5-diphenylpyra zolium methylsulphate; difenzoquat methyl sulfate 256-152-5 43222-48-6 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 H302 H400 … 2,023 unchanged lines … Wng H317 H410 M = 100 M = 100 613-328-00-X 1-vinylimidazole 214-012-0 1072-63-5 Repr. 1B H360D GHS08 Dgr H360D Repr. 1B; H360D: C ≥ 0,03 % 614-001-00-4 nicotine (ISO); Dgr H360D Repr. 1B; H360D: C ≥ 0,03 % 613-329-00-5 halosulfuron-methyl (ISO); methyl 3-chloro-5-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-1-methyl-1H-pyrazole-4-carboxylate — 100784-20-1 Repr. 1B Aquatic Acute 1 Aquatic Chronic 1 H360D H400 H410 GHS08 GHS09 Dgr H360D H410 M = 1000 M = 1000 613-330-00-0 2-methylimidazole 211-765-7 693-98-1 Repr. 1B H360Df GHS08 Dgr H360Df 614-001-00-4 nicotine (ISO); 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine 200-193-3 54-11-5 Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 … 864 unchanged lines … GHS09 Wng H312 H302 H410 616-018-00-2 N,N-diethyl-m-toluamide; deet 205-149-7 134-62-3 Acute Tox. 4 * Eye Irrit. 2 H410 616-018-00-2 diethyltoluamide (ISO): N,N-diethyl-m-toluamide; [deet] 205-149-7 134-62-3 Acute Tox. 4 Skin Irrit. 2 Aquatic Chronic 3 H302 H319 Eye Irrit. 2 H302 H315 H412 GHS07 H319 GHS07 Wng H302 H319 H315 H412 616-019-00-8 perfluidone (ISO); H319 oral: ATE = 1892 mg/kg bw 616-019-00-8 perfluidone (ISO); 1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide; 253-718-3 37924-13-3 Acute Tox. 4 * Eye Irrit. 2 H302 H319 GHS07 … 975 unchanged lines … Wng H351 H319 H410 M = 10 M = 10 617-001-00-2 di-tert-butyl peroxide 203-733-6 110-05-4 Org. Perox. E Flam. Liq. 2 Muta. 2 H242 M = 10 616-225-00-8 (RS)-2-methoxy-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide; mandestrobin — 173662-97-0 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 M = 1 M = 10 616-226-00-3 carboxin (ISO); 2-methyl-N-phenyl-5,6-dihydro-1,4-oxathiine-3-carboxamide; 5,6-dihydro-2-methyl-1,4-oxathiine-3-carboxanilide 226-031-1 5234-68-4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H373 (kidneys) H317 H400 H410 GHS08 GHS07 GHS09 Wng H373 (kidneys) H317 H410 M = 1 M = 1 616-227-00-9 metaflumizone (ISO); (EZ)-2’-[2-(4-cyanophenyl)-1-(α,α,α -trifluoro-m-tolyl)ethylidene]-[4-(trifluoromethoxy)phenyl]carbanilohydrazide [E-isomer ≥ 90 %, Z-isomer ≤ 10 % relative content]; [1] (E)-2’-[2-(4-cyanophenyl)-1-(α,α,α -trifluoro-m-tolyl)ethylidene]-[4-(trifluoromethoxy)phenyl]carbanilohydrazide [2] — 139968-49-3 [1] 852403-68-0 [2] Repr. 2 Lact. STOT RE 2 H361fd H362 H373 GHS08 Wng H361fd H362 H373 617-001-00-2 di-tert-butyl peroxide 203-733-6 110-05-4 Org. Perox. E Flam. Liq. 2 Muta. 2 H242 H225 H341 GHS02 GHS08 … 5,196 unchanged lines … 1,3-butanediol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionate] isomers 423-600-8 — Aquatic Chronic 2 H411 GHS09 H411 650-055-00-5 silver sodium zirconium hydrogenphosphate 422-570-3 155925-27-2 Aquatic Acute 1 Aquatic Chronic 1 H400 H410 GHS09 Wng H410 Table 3.2 Wng H410 650-056-00-0 dibutylbis(pentane-2,4-dionato-O,O’)tin 245-152-0 22673-19-4 Repr. 1B STOT RE 1 H360FD H372 (immune system) GHS08 Dgr H360FD H372 (immune system) Table 3.2 The list of harmonised classification and labelling of hazardous substances from Annex I to Directive 67/548/EEC Index No International Chemical Identification EC No CAS No Classification Labelling Concentration Limits Notes 001-001-00-9 hydrogen 215-605-7 1333-74-0 F+; R12 F+ … 19,751 unchanged lines … S: 61 650-055-00-5 silver sodium zirconium hydrogenphosphate 422-570-3 155925-27-2 N; R50-53 N R: 50/53 S: 60-61